Tag: relaypro

Terumo Aortic announces first commercial implants of RelayPro endovascular device in...

Following the recent approval by the US Food and Drug Administration (FDA) of the RelayPro thoracic stent graft system for the treatment of patients...

Terumo Aortic announces US FDA approval for RelayPro endovascular device

Terumo Aortic has announced that the US Food and Drug Administration (FDA) has granted approval of its RelayPro thoracic stent-graft system for sale in...

RelayPro US transection pivotal study completes enrolment

Terumo Aortic has announced completion of enrolment of the RelayPro traumatic injury (RelayPro-T) investigational device exemption (IDE) study in the USA. RelayPro is a...

Terumo Aortic announces completion of enrolment of RelayPro US pivotal study

Terumo Aortic has announced the completion of enrolment of the RelayPro pivotal study in the USA. RelayPro is a low profile, next generation thoracic...

RelayBranch early feasibility study begins enrolment

The first two patients have been successfully enrolled in the RelayBranch Early Feasibility Study. This trial will assess the safety and efficacy of the...

CX 2018: Terumo Aortic launches RelayPro thoracic stent graft in Europe

Terumo Aortic have announced the European limited market release of the RelayPro thoracic stent graft system at the 2018 Charing Cross Symposium (CX; 24–27...
Bolton Medical Relay

First patient enrolled in Bolton Medical’s RelayPro FDA trial

The first patient has been enrolled in Bolton Medical’s RelayPro US Food and Drug Administration (FDA) Phase II clinical trial. This study will assess the...